RBM41 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.476600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.976600E-01
Normal-vs-Stage2
3.025600E-01
Normal-vs-Stage3
9.251000E-01
Normal-vs-Stage4
1.408790E-01
Stage1-vs-Stage2
6.045200E-01
Stage1-vs-Stage3
2.138000E-01
Stage1-vs-Stage4
4.639400E-01
Stage2-vs-Stage3
2.101800E-01
Stage2-vs-Stage4
1.032390E-01
Stage3-vs-Stage4
8.306100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.698600E-01
Normal-vs-AfricanAmerican
1.543400E-01
Normal-vs-Asian
5.077000E-01
Caucasian-vs-AfricanAmerican
3.729000E-01
Caucasian-vs-Asian
6.057800E-01
AfricanAmerican-vs-Asian
2.534400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.678200E-01
Normal-vs-Female
3.349800E-01
Male-vs-Female
7.397800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.271800E-01
Normal-vs-Age(41-60Yrs)
1.924040E-01
Normal-vs-Age(61-80Yrs)
4.614600E-01
Normal-vs-Age(81-100Yrs)
4.147400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.311200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.020000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.144000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.704500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.136800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.764800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.889000E-01
Normal-vs-Daily Drinker
6.862000E-01
Normal-vs-Weekly Drinker
4.969800E-01
Normal-vs-Occasional Drinker
3.084800E-01
Normal-vs-Social Drinker
1.979380E-01
Non Drinker-vs-Daily Drinker
2.913800E-01
Non Drinker-vs-Weekly Drinker
8.543800E-01
Non Drinker-vs-Occasional Drinker
3.460600E-01
Non Drinker-vs-Social Drinker
2.757000E-01
Daily Drinker-vs-Weekly Drinker
5.495200E-01
Daily Drinker-vs-Occasional Drinker
1.120430E-01
Daily Drinker-vs-Social Drinker
9.574400E-02
Weekly Drinker-vs-Occasional Drinker
3.841200E-01
Weekly Drinker-vs-Social Drinker
3.631600E-01
Occasional Drinker-vs-Social Drinker
9.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.631700E-02
Normal-vs-Grade 2
1.688060E-02
Normal-vs-Grade 3
9.382000E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.260200E-02
Grade 1-vs-Grade 3
1.384590E-03
Grade 1-vs-Grade 4
9.631700E-02
Grade 2-vs-Grade 3
4.912100E-02
Grade 2-vs-Grade 4
1.688060E-02
Grade 3-vs-Grade 4
9.382000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.900200E-01
Normal-vs-NonDiabetic
3.602600E-01
Diabetic-vs-NonDiabetic
1.373840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.052500E-02
Normal-vs-NoPancreatitis
4.496600E-01
Pancreatitis-vs-NoPancreatitis
1.802040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.762200E-01
Normal-vs-N1
3.173000E-01
N0-vs-N1
6.883400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.121840E-01
Normal-vs-TP53-NonMutant
4.617200E-01
TP53-Mutant-vs-TP53-NonMutant
4.239800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
